Cartilage Biomarkers Coll2-1 and Coll2-1NO2 Are Associated with Knee OA MRI Features and Are Helpful in Identifying Patients at Risk of Disease Worsening
暂无分享,去创建一个
D. Loeuille | M. Malaise | Y. Maugars | Y. Henrotin | T. Conrozier | F. Pelousse | A. Hick | C. Tits | Anne-Christine Hick
[1] Y. Henrotin,et al. Serum Levels of Coll2-1, a Specific Biomarker of Cartilage Degradation, Are Not Affected by Sampling Conditions, Circadian Rhythm, and Seasonality. , 2019, Cartilage.
[2] A. Mobasheri,et al. Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover – biomarkers to facilitate the treatment of osteoarthritis? , 2019, Expert review of molecular diagnostics.
[3] Ali Mobasheri,et al. Osteoarthritis phenotypes and novel therapeutic targets. , 2019, Biochemical pharmacology.
[4] J. Parvizi,et al. Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF-β1 , 2019, The Journal of Knee Surgery.
[5] M. Nevitt,et al. Associations between molecular biomarkers and MR-based cartilage composition and knee joint morphology: data from the Osteoarthritis Initiative. , 2018, Osteoarthritis and cartilage.
[6] C. McCulloch,et al. Role of thigh muscle cross-sectional area and strength in progression of knee cartilage degeneration over 48 months - data from the Osteoarthritis Initiative. , 2016, Osteoarthritis and cartilage.
[7] M. Nevitt,et al. MRI findings associated with development of incident knee pain over 48 months: data from the osteoarthritis initiative , 2016, Skeletal Radiology.
[8] L. Sharma,et al. Baseline radiographic osteoarthritis and semi-quantitatively assessed meniscal damage and extrusion and cartilage damage on MRI is related to quantitatively defined cartilage thickness loss in knee osteoarthritis: the Multicenter Osteoarthritis Study. , 2015, Osteoarthritis and cartilage.
[9] S. Majumdar,et al. Higher Knee Flexion Moment During the Second Half of the Stance Phase of Gait Is Associated With the Progression of Osteoarthritis of the Patellofemoral Joint on Magnetic Resonance Imaging. , 2015, The Journal of orthopaedic and sports physical therapy.
[10] F. Rannou,et al. Early decrease of serum biomarkers of type II collagen degradation (Coll2‐1) and joint inflammation (Coll2‐1 NO2) by hyaluronic acid intra‐articular injections in patients with knee osteoarthritis: A research study part of the Biovisco study , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[11] M. Nevitt,et al. Predictive validity of within-grade scoring of longitudinal changes of MRI-based cartilage morphology and bone marrow lesion assessment in the tibio-femoral joint--the MOST study. , 2012, Osteoarthritis and cartilage.
[12] G. Baxter,et al. Patient characteristics that predict progression of knee osteoarthritis: A systematic review of prognostic studies , 2011, Arthritis care & research.
[13] M. Nevitt,et al. Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study. , 2009, Radiology.
[14] R. Cancedda,et al. Cartilage and bone extracellular matrix. , 2009, Current pharmaceutical design.
[15] M. Nevitt,et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis , 2008, Annals of the rheumatic diseases.
[16] J. Reginster,et al. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. , 2005, Osteoarthritis and cartilage.
[17] H. Genant,et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. , 2004, Osteoarthritis and cartilage.
[18] E. Roos,et al. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis , 2003, Health and quality of life outcomes.
[19] M. Dougados,et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. , 2003, The Journal of rheumatology.
[20] R. Moskowitz,et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.
[21] A. Mobasheri,et al. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes , 2019, Current opinion in rheumatology.
[22] D’Apuzzo,et al. Could Whole-Organ Magnetic Resonance Imaging Score ( WORMS ) Components Predict Pain in Knee Osteoarthritis ? , 2011 .